New indications for exenatide therapy of type 2 diabetes mellitus

New indications for exenatide therapy of type 2 diabetes mellitus

Obesity associated with the enhanced risk of cardiovascular disorders plays a key role in the evolvement and progression of type 2 diabetes mellitus(DM2). Incretin mimetics are the sole class of hypoglycemic agents that not only effectively correct hyperglycemia but also reduce body weight. Exenatid...

Full description

Saved in:
Bibliographic Details
Main Authors: Olga Konstantinovna Vikulova, Marina Vladimirovna Shestakova
Format: Article
Language:English
Published: Endocrinology Research Centre 2010-09-01
Series:Сахарный диабет
Subjects:
type 2 diabetes mellitus
obesity
incretin mimetics
exenatide
byetta
Online Access:https://www.dia-endojournals.ru/jour/article/view/5496
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items

Similar Items